Inhibition of HIV replication by liposomal encapsulated amphotericin B
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 11 (3) , 119-125
- https://doi.org/10.1016/0166-3542(89)90023-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- How do the polyene macrolide antibiotics affect the cellular membrane properties?Published by Elsevier ,2003
- Molecular Pharmacologic Approaches to the Treatment of AidsAnnual Review of Pharmacology and Toxicology, 1988
- Lipids are major components of human immunodeficiency virus (HIV): Modification of HIV lipid composition, membrane organization, and protein conformation by AL-721®Drug Development Research, 1988
- The AIDS VirusScientific American, 1987
- Anti-viral activity of amphotericin B methyl ester: inhibition ofHTLV-III replication in cell cultureBiochemical Pharmacology, 1986
- Inhibition of HTLV-III/LAV replication by foscarnetBiochemical Pharmacology, 1985
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis1American Review of Respiratory Disease, 1982
- Immune responses in vitro. I. Culture conditions for antibody synthesisCellular Immunology, 1972